Mr. Thomas Appio reports
BAUSCH HEALTH'S AESTHETICS BUSINESS, SOLTA MEDICAL, ANNOUNCES THE LAUNCH OF CLEAR + BRILLIANT TOUCH LASER IN CANADA
Bausch Health Companies Inc. and Solta Medical have launched the Clear + Brilliant
touch laser in Canada. The device was approved by Health Canada on May 20, 2025, marking an important milestone as demand for non-invasive skin rejuvenation treatments continues to grow across Canada. With this approval, Canadian physicians are able to offer one of the most advanced dual-wavelength laser technologies on the market, expanding access to customizable treatments that align with the country's growing preference for effective yet approachable skin rejuvenation options.
"The Solta business continues to expand its global presence through its diverse and well-established portfolio that supports the growing demand for high-quality aesthetics solutions," said Thomas J. Appio, chief executive officer, Bausch Health. "Canada is an important part of that growth, reflecting strong and sustained interest in the aesthetic market across the country."
Building on the successful United States launch of the Clear + Brilliant touch system in 2021, the device's innovative design allows for seamless use of two hand pieces with unique wavelengths to deliver comprehensive treatments that help reveal smoother, more radiant, youthful-looking skin. The system is suitable for all skin types, a wide range of ages, can be used year-round (at the discretion of the treating physician) and is recognized for its ease of use, minimal downtime, and gentle and effective results.
"Expanding the availability of the Clear + Brilliant touch system into Canada marks a significant step forward for Solta Medical and its commitment to global expansion of our innovative portfolio of products in skin health," said Jiny Kim, senior vice-president, Solta Medical, Bausch Health. "This launch reinforces Solta's leadership in supporting both providers and patients with technology that delivers safe, effective and customizable results."
Clear + Brilliant
touch laser indications (Canada)
The Clear + Brilliant
touch system is indicated for use in dermatological procedures requiring the coagulation of soft tissue and general skin resurfacing. The system includes two distinct fractional laser hand pieces, each with its own indication:
1440 nm hand piece
-
Indicated for the treatment of and improvement in the appearance of:
-
Wrinkles;
- Dyschromia;
- Pigmentation;
- Skin texture;
- Pore size.
1927 nm hand piece
-
Indicated for the treatment of and improvement in the appearance of:
-
Wrinkles;
- Dyschromia;
- Pigmentation;
- Skin texture;
- Enhancement of skin permeability;
- Pore size.
About the Clear + Brilliant
touch laser
Solta Medical's Clear + Brilliant
touch laser is now available in Canada, joining the Clear + Brilliant portfolio. Supported by robust, evidence-based data, including more than 15 clinical studies, the Clear + Brilliant laser platform uses fractional laser technology to create structural and functional changes in the skin. In Canada, these treatments help address early signs of aging, maintain youthful-looking skin and improve the skin's overall appearance.
Since 2011, the Clear + Brilliant platform has helped define the laser-treatment landscape across global markets.
About Bausch Health Companies Inc.
Bausch Health Companies is a global, diversified pharmaceutical company enriching lives through the company's relentless drive to deliver better health care outcomes. Bausch develops, manufactures and markets a range of products primarily in gastroenterology, hepatology, neuroscience, dermatology, dentistry, aesthetics, international pharmaceuticals and eye health, through the company's controlling interest in Bausch + Lomb. The company's ambition is to be a globally integrated healthcare company, trusted and valued by patients, HCPs, employees and investors. Bausch's aesthetic business, Solta Medical, is a global leader in the aesthetics market, whose vision is to develop and support trusted aesthetic brands that provide value to the company's customers and patients.
We seek Safe Harbor.
© 2026 Canjex Publishing Ltd. All rights reserved.